DermDocs

Candrice Heath, MD, discusses key takeaways regarding disparities in the treatment of atopic dermatitis and scalp/hair conditions in pediatric patients with skin of color, including: Can you highlight some of the systemic issues that contribute to a lack of knowledge about atopic dermatitis in patients of color, particularly in the pediatric patient population? (This is in reference to lack of div...

Susan Taylor, MD, shares some clinical pearls from regarding the treatment of acne patients with skin of color, including: Can you highlight some of the systemic issues that contribute to a lack of knowledge about acne in patients of color? (This is in reference to lack of diversity in clinical trials, lack of training involving skin of color, etc.) Can you explain why it is important to treat pos...

Andrew Alexis, MD, shares some highlights regarding the treatment of atopic dermatitis and psoriasis in patients with skin of color, including: Can you highlight some of the systemic issues that contribute to a lack of knowledge about acne in patients of color? (This is in reference to lack of diversity in clinical trials, lack of training involving skin of color, etc.) Can you explain why certain...

Amy McMichael, MD, Chair of the LiVDerm Deep Dive Racial Disparities in Dermatology program, shares highlights the current health disparities in dermatologic care for patients with skin of color, including: Can you give us a brief overview of the LiVDerm Deep Dive Racial Disparities program and why it is important to dermatologists?  Can you highlight some of the systemic issues that specifically...

Mark Lebwohl, MD, discusses the new and emerging therapies for treatment of psoriasis, including: Can you elaborate on the different classes of biologics currently indicated for treatment of psoriasis? What are some of the most promising therapies that will likely be part of the psoriasis treatment table in the near future? Do you foresee that they will be also approved for pediatric psoriasis pat...

Adelaide Hebert, MD, shares some highlights and clinical pearls about treatment of psoriasis in pediatric patients, including: What is your personal approach to treating psoriasis in pediatric patients compared to other age groups? Can you highlight the different class of therapeutics currently indicated to treat pediatric patients with psoriasis? Are there any considerations to be made when presc...

Latanya Benjamin, MD, shares clinical pearls about the management of atopic dermatitis in pediatric patients with skin of color, including: Can you tell us about the number of emerging therapies for treatment of AD in pediatric patients and how this will change the treatment landscape? What is your personal approach to treating AD in pediatric patients with skin of color? Can you share some advice...

Lawrence Schachner, MD, discusses recent developments in the pediatric atopic dermatitis treatment landscape, including: Can you share some advice for dermatologists on communicating with parents and caretakers of pediatric AD patients regarding treatment options and at-home interventions? Dupilumab is currently approved for patients with atopic dermatitis aged 6 years and older. Do you foresee du...

Candrice Heath, MD, shares some highlights from the Pediatric Skin of Color Symposium about the treatment of acne in pediatric patients with skin of color, including: What is your personal approach to treating acne in patients with skin of color? Can you tell us about the approved and emerging therapies for treatment of acne in pediatric patients? Have any of them been studied in patient populatio...

Latanya Benjamin, MD, shares some highlights from the Pediatric Skin of Color Symposium at MOPD about the treatment of atopic dermatitis in pediatric patients with skin of color, including: Can you tell us about the number of emerging therapies for treatment of AD in pediatric patients and how this will change the treatment landscape? What is your personal approach to treating AD in pediatric pati...

Amy McMichael, MD, Chair of the CME Symposium "Diversity in Derm Treatments: Skin of Color" at SBS 2021, leads a panel discussion with Valerie Callender, MD, and Seemal Desai, MD, to share clinical pearls and key takeaways about treatment of dermatologic conditions in patients with skin of color.

Glenn Speer, PhD, has been working with dermatologists to manage his psoriatic arthritis symptoms for over 20 years. In this video interview, Glenn tells his story, including: Can you share with us your experience of your path to diagnosis? Can you tell us about what type of treatments you tried and how long and how long it took you to identify the best treatment? Can you share more with us about...

Alice Gottlieb, MD, Chair of the CME symposium "Time to Think About Both Skin and Joint Disease: Optimizing the Diagnosis and Management of Psoriatic Arthritis" at SBS 2021, shares some clinical pearls about the dermatologist's role in screening and diagnosing psoriatic arthritis, including: Can you tell us about screening tools that are currently available for psoriatic arthritis patients? What i...

Lawrence Schachner, MD, shares some clinical pearls about treatment of acne and antibiotic stewardship in pediatric patients, including: What do dermatologists need to keep in mind when prescribing treatments for pediatric patients with acne? How do these new acne treatments address the issue of antibiotic resistance? Can you tell us more about the effects of these new acne treatments on the micro...

Diane Berson, MD, shares additional clinical pearls on the treatment of acne and antibiotic stewardship, including: Can you discuss how the microbiome is affected in treatment of acne patients? Can you explain which antibiotics are better in terms of resistance? What are the core principles of antibiotic stewardship? What is your personal approach to minimizing antibiotic resistance in acne?

Jonette Keri, MD, shares some highlights about treatment of acne in preteen patients, including: What is your personal approach to treating acne in preteen patients compared to other age groups? What is your advice for dermatologists to keep in mind when treating preteen patients with acne? Can you tell us more about the efficacy and safety of these new acne medications for children and adolescent...

James Del Rosso, DO, discusses new and emerging therapies for treatment of acne patients, including: What is your personal approach for exploring alternative treatments for acne patients beyond first-line therapies? Can you compare the emerging topical treatments for acne? What are some advantages with the newer topical retinoids? How do these new acne treatments address the issue of antibiotic re...

Candrice Heath, MD, shares clinical pearls about the treatment of acne in pediatric patients with skin of color, including: What is your personal approach to treating acne in patients with skin of color? Can you tell us about the approved and emerging therapies for treatment of acne in pediatric patients? Have any of them been studied in patient populations with skin of color? Can you explain why...

Jonette Keri, MD, PhD, shares some highlights about acne evaluation and treatment across the age spectrum, including: • How do we differentiate and grade acne across the age spectrum, from newborns to preteens? • When is it necessary to refer, particularly to endocrinology or other specialties, for childhood acne that may be associated with an underlying endocrine disorder? • What should we be usi...

Diane Berson, MD, shares additional clinical pearls on the treatment of adult female acne, including: • What are some typical acne presentations seen in adult women? • Can acne in women persist beyond menopause? • Can some of the newer non-oral contraceptives exacerbate acne flares? What are the options in this case? • Is there a concern with hyperkalemia in patients taking spironolactone for acne...

James Del Rosso, MD, shares clinical pearls about common controversies and recent developments in acne therapy, including: What is your approach to minimizing antibiotic resistance in acne? Are the newer antibiotics better in terms of resistance? Why are dermatologists hesitant in using oral isotretinoin? What are some of the advantages with the newer topical retinoids? Should we pay more attentio...

Michael Gold, MD, discusses additional takeaways on laser and light therapy for acne, including: How do you explain the absence of light and laser therapies from the global alliance acne treatment algorithm? Do you think that there is enough evidence to recommend their addition to the treatment guidelines? How do lasers/light therapies for acne challenge the current treatment status quo? How do th...